The NIH Clinical Trial Integrity Act aims to enhance the diversity of participants in clinical trials, ensuring that medical treatments are safe and effective for all demographic groups. By establishing clear goals and requirements for participant recruitment and retention, the Act seeks to address the historical underrepresentation of various racial, ethnic, age, and gender backgrounds in clinical research.